{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:56:41Z","timestamp":1784577401833,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100012166","name":"973 program","doi-asserted-by":"crossref","award":["2013CB530800"],"award-info":[{"award-number":["2013CB530800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012164","name":"863 program","doi-asserted-by":"crossref","award":["2012AA02A512"],"award-info":[{"award-number":["2012AA02A512"]}],"id":[{"id":"10.13039\/501100012164","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Project of Beijing","award":["D131100004713003"],"award-info":[{"award-number":["D131100004713003"]}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["81171645"],"award-info":[{"award-number":["81171645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Technology RD Program","award":["2013BAI09B05"],"award-info":[{"award-number":["2013BAI09B05"]}]},{"name":"National Key Technology RD Program","award":["2011BAI10B00"],"award-info":[{"award-number":["2011BAI10B00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0482-0","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T12:01:14Z","timestamp":1487160074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy"],"prefix":"10.1186","volume":"18","author":[{"given":"Shuang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Guang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"482_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000045989","volume":"88","author":"I Rantala","year":"2001","unstructured":"Rantala I, Mustonen J, Hurme M, Syrj\u00e4nen J, Helin H. Pathogenetic aspects of IgA nephropathy. Nephron. 2001;88:193\u20138.","journal-title":"Nephron"},{"key":"482_CR2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1523-1755.2005.00146.x","volume":"67","author":"PJ Boog van der","year":"2005","unstructured":"van der Boog PJ, van Kooten C, de Fijter JW, Daha MR. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005;67:813\u201321.","journal-title":"Kidney Int"},{"key":"482_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1440-1797.2003.00128.x","volume":"8","author":"CS Lim","year":"2003","unstructured":"Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, et al. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology (Carlton). 2003;8:21\u20137.","journal-title":"Nephrology (Carlton)"},{"key":"482_CR4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738\u201348.","journal-title":"N Engl J Med"},{"key":"482_CR5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102\u201314.","journal-title":"Nat Rev Genet"},{"key":"482_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","volume":"26","author":"TC Chang","year":"2007","unstructured":"Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007;26:745\u201352.","journal-title":"Mol Cell"},{"key":"482_CR7","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1073\/pnas.0707351104","volume":"104","author":"H Tazawa","year":"2007","unstructured":"Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A. 2007;104:15472\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"482_CR8","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1007\/s00018-014-1599-y","volume":"71","author":"D Chen","year":"2014","unstructured":"Chen D, Li Y, Mei Y, Geng W, Yang J, Hong Q, et al. MiR-34a regulates mesangial cell proliferation via the PDGFR-\u03b2\/Ras-MAPK signaling pathway. Cell Mol Life Sci. 2014;71:4027\u201342.","journal-title":"Cell Mol Life Sci"},{"key":"482_CR9","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1074\/jbc.M111.227611","volume":"286","author":"AA Dar","year":"2011","unstructured":"Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M. MiRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem. 2011;286:16606\u201314.","journal-title":"J Biol Chem"},{"key":"482_CR10","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4161\/cc.7.20.6851","volume":"7","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008;7:3112\u20138.","journal-title":"Cell Cycle"},{"key":"482_CR11","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"482_CR12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","volume":"207","author":"G Liu","year":"2010","unstructured":"Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, et al. MiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207:1589\u201397.","journal-title":"J Exp Med"},{"key":"482_CR13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980\u20134.","journal-title":"Nature"},{"key":"482_CR14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00125-012-2804-x","volume":"56","author":"X Zhong","year":"2013","unstructured":"Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, et al. MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia. 2013;56:663\u201374.","journal-title":"Diabetologia"},{"key":"482_CR15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12013-013-9539-2","volume":"67","author":"J Wang","year":"2013","unstructured":"Wang J, Gao Y, Ma M, Li M, Zou D, Yang J, et al. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem Biophys. 2013;67:537\u201346.","journal-title":"Cell Biochem Biophys"},{"key":"482_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000324949","volume":"170","author":"HY Lan","year":"2011","unstructured":"Lan HY, Chung AC. Transforming growth factor-beta and Smads. Contrib Nephrol. 2011;170:75\u201382.","journal-title":"Contrib Nephrol"},{"key":"482_CR17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molcel.2010.07.011","volume":"39","author":"BN Davis","year":"2010","unstructured":"Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell. 2010;39:373\u201384.","journal-title":"Mol Cell"},{"key":"482_CR18","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1042\/BST0361211","volume":"36","author":"AE Williams","year":"2008","unstructured":"Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans. 2008;36:1211\u20135.","journal-title":"Biochem Soc Trans"},{"key":"482_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","volume":"1792","author":"I Faraoni","year":"2009","unstructured":"Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta. 2009;1792:497\u2013505.","journal-title":"Biochim Biophys Acta"},{"key":"482_CR20","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar2493","volume":"10","author":"KM Pauley","year":"2008","unstructured":"Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther. 2008;10:R101\u20132.","journal-title":"Arthritis Res Ther"},{"key":"482_CR21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","volume":"58","author":"J Stanczyk","year":"2008","unstructured":"Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001\u20139.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"482_CR22","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","volume":"2","author":"E Sonkoly","year":"2007","unstructured":"Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007;2(7):e610.","journal-title":"PLoS One"},{"key":"482_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2215\/CJN.04820511","volume":"7","author":"JK Kim","year":"2012","unstructured":"Kim JK, Kim JH, Lee SC, Kang EW, Chang TI, Moon SJ, et al. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol. 2012;7:427\u201336.","journal-title":"Clin J Am Soc Nephrol"},{"key":"482_CR24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1479-5876-12-194","volume":"12","author":"Z Ni","year":"2014","unstructured":"Ni Z, Yuan Y, Wang Q, Cao L, Che X, Zhang M, et al. Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission. J Transl Med. 2014;12:194.","journal-title":"J Transl Med"},{"key":"482_CR25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"482_CR26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of micro RNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997\u20131006.","journal-title":"Cell Res"},{"key":"482_CR27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1373\/clinchem.2010.147553","volume":"56","author":"C Zhang","year":"2010","unstructured":"Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem. 2010;56:1871\u20139.","journal-title":"Clin Chem"},{"key":"482_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2010.06.010","volume":"39","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39:133\u201344.","journal-title":"Mol Cell"},{"key":"482_CR29","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223\u201333.","journal-title":"Nucleic Acids Res"},{"key":"482_CR30","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"482_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2011\/304852","volume":"30","author":"G Wang","year":"2011","unstructured":"Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC. Elevated levels of miR-146a andmiR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers. 2011;30:171\u20139.","journal-title":"Dis Markers"},{"key":"482_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/0961203310389841","volume":"20","author":"G Wang","year":"2011","unstructured":"Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus. 2011;20:493\u2013500.","journal-title":"Lupus"},{"key":"482_CR33","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","volume":"447","author":"L He","year":"2007","unstructured":"He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130\u20134.","journal-title":"Nature"},{"key":"482_CR34","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.febslet.2008.03.057","volume":"582","author":"F Sun","year":"2008","unstructured":"Sun F, Hanjiang F, Liu Q, Tie Y, Zhu J, Xing R, et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008;582:1564\u20138.","journal-title":"FEBS Lett"},{"key":"482_CR35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","volume":"17","author":"GT Bommer","year":"2007","unstructured":"Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. P53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007;17:1298\u2013307.","journal-title":"Curr Biol"},{"key":"482_CR36","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1038\/sj.onc.1210293","volume":"26","author":"C Welch","year":"2007","unstructured":"Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007;26:5017\u201322.","journal-title":"Oncogene"},{"key":"482_CR37","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1681\/ASN.2010080793","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 2010;21:1819\u201334.","journal-title":"J Am Soc Nephrol"},{"key":"482_CR38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nm.2135","volume":"16","author":"W Bechtel","year":"2010","unstructured":"Bechtel W, McGoohan S, Zeisberg EM, M\u00fcller GA, Kalbacher H, Salant DJ, et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010;16:544\u201350.","journal-title":"Nat Med"},{"key":"482_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000168068","volume":"10","author":"O Bogensch\u00fctz","year":"1990","unstructured":"Bogensch\u00fctz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, et al. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol. 1990;10:137\u201347.","journal-title":"Am J Nephrol"},{"issue":"1","key":"482_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/mmr.2014.2179","volume":"10","author":"J Yao","year":"2014","unstructured":"Yao J, Ke Z, Wang X, Peng F, Li B, Wu R. Epithelial-mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy. Mol Med Rep. 2014;10(1):39\u201344.","journal-title":"Mol Med Rep"},{"issue":"121","key":"482_CR41","first-page":"121ra18","volume":"4","author":"BN Chau","year":"2012","unstructured":"Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med. 2012;4(121):121ra18.","journal-title":"Sci Transl Med"},{"issue":"8","key":"482_CR42","doi-asserted-by":"crossref","first-page":"e23011","DOI":"10.1371\/journal.pone.0023011","volume":"6","author":"MD Shapiro","year":"2011","unstructured":"Shapiro MD, Bagley J, Latz J, Godwin JG, Ge X, Tullius SG, et al. MicroRNA expression data reveals a signature of kidney damage following ischemia reperfusion injury. PLoS One. 2011;6(8):e23011.","journal-title":"PLoS One"},{"issue":"2","key":"482_CR43","doi-asserted-by":"crossref","first-page":"e58014","DOI":"10.1371\/journal.pone.0058014","volume":"8","author":"F Glowacki","year":"2013","unstructured":"Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One. 2013;8(2):e58014.","journal-title":"PLoS One"},{"key":"482_CR44","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2010111168","volume":"22","author":"X Zhong","year":"2011","unstructured":"Zhong X, Chung AC, Chen HY, Meng XM, Lan HY. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol. 2011;22:1668\u201381.","journal-title":"J Am Soc Nephrol"},{"key":"482_CR45","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-11-0494","volume":"17","author":"JH Paik","year":"2011","unstructured":"Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, et al. MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK\/T cell lymphoma. Clin Cancer Res. 2011;17:4761\u201371.","journal-title":"Clin Cancer Res"},{"key":"482_CR46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","volume":"139","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244\u201352.","journal-title":"Ann Intern Med"},{"key":"482_CR47","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ndt\/17.7.1197","volume":"17","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002;17:1197\u2013203.","journal-title":"Nephrol Dial Transplant"},{"key":"482_CR48","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","volume":"18","author":"HN Reich","year":"2007","unstructured":"Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177\u201383.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T15:48:27Z","timestamp":1589730507000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0482-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"article-number":"63"}}